| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.290 | 24.009 | 51.345 | 75.551 | 57.675 | 57.407 | 90.466 | 123.703 | 108.288 |
| Total Income - EUR | - | 8.290 | 24.009 | 51.346 | 75.551 | 57.675 | 57.407 | 90.692 | 123.703 | 108.288 |
| Total Expenses - EUR | - | 6.766 | 12.649 | 14.884 | 15.365 | 9.888 | 10.845 | 19.554 | 16.698 | 37.124 |
| Gross Profit/Loss - EUR | - | 1.524 | 11.360 | 36.462 | 60.186 | 47.788 | 46.562 | 71.138 | 107.005 | 71.165 |
| Net Profit/Loss - EUR | - | 1.433 | 11.120 | 35.948 | 59.430 | 47.211 | 45.988 | 70.448 | 105.855 | 67.981 |
| Employees | - | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Popicardio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 13.056 | 9.234 | 22.613 | 16.744 | 12.230 | 10.321 |
| Current Assets | - | 7.176 | 13.162 | 42.818 | 59.640 | 48.813 | 42.155 | 64.826 | 94.749 | 62.500 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 5.533 | 5.766 | 4.259 | 5.139 | 7.325 | 9.701 | 32.992 | 0 |
| Cash | - | 7.176 | 7.630 | 37.052 | 55.381 | 43.673 | 34.830 | 55.125 | 61.757 | 62.500 |
| Shareholders Funds | - | 1.468 | 11.163 | 35.991 | 59.472 | 47.261 | 46.037 | 70.498 | 105.904 | 68.030 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 5.708 | 2.000 | 6.827 | 13.224 | 10.786 | 18.730 | 11.072 | 1.074 | 4.791 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Popicardio Srl